Where does Inari Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inari Medical, Inc. ranks #5,291 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inari Medical, Inc. hold?

Inari Medical, Inc. holds 65 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Inari Medical, Inc.'s Innovation Score?

Inari Medical, Inc. has an Innovation Score of 53.5 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Inari Medical, Inc. focus on?

Inari Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 63 patents, ranking #292 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Inari Medical, Inc.'s patent grant rate increasing or decreasing?

Inari Medical, Inc.'s recent grant velocity is +390% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Inari Medical, Inc.'s patents?

Inari Medical, Inc.'s patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Inari Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Inari Medical, Inc.

USPTO PatentsView assignee record - 65 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inari ranks #5,291 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 4 technology areas.

#5,291
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.5/100): 20.0
avg claims per patent: +390%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5291 · US Corporation #5,291 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,291/49,997
PHOTO-FINISH Headwater Partners II
CPC-NARROW A61B · 4 areas
INNOV-PAR 53.5/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +390% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Headwater Partners II LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bekaert · near

54
Inari Medical · this assignee

54
National University… · near

54
University of… · near

54
Novamont S p A · near

54
3D Lighting… · lowest

7

What this shows Inari's Innovation Score is 53.5/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Inari's grants concentrate

Inari Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 96.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (24 grants) versus a trough of 1 in 2016. By volume, Inari sits between Hydac Technology GMBH and Juno Therapeutics, Inc..

Inari's three-year grant acceleration

Inari Medical, Inc. shows 40 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hydac Technology

65
Headwater Partner…

65
Himax Display

65
Innoscience (Suzh…

65
Inventec Applianc…

65
Jusung Engineering

65
Johnstech Interna…

65
Juno Therapeutics

65
Inari Medical ◀

65

What this shows Inari holds 65 patents at rank #5,291, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inari

By rank, the assignees closest to #5,291 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Inari's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Inari, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Inari ranks #292 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

NV Bekaert SA 54 National University Corporation Kagawa University 54 University of Newcastle Upon Tyne 54 Novamont S.p.A. 54

Similar claim depth

Nearest assignees by average claims per patent (20.0 here).

Nielsen Consumer LLC 20.0 avg Prysm, Inc. 20.0 avg Empower Semiconductor, Inc. 20.0 avg US Synthetic Corporation 20.0 avg

Inari's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Inari Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	1.5%
2017	2	3.1%
2018	3	4.6%
2019	4	6.2%
2020	3	4.6%
2021	6	9.2%
2022	2	3.1%
2023	14	21.5%
2024	24	36.9%
2025partial year	6	9.2%

Which technologies does Inari Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 63

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 39

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 30

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 2

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#5,291

of 49,997 tracked assignees

Innovation Score

53.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Inari Medical, Inc.'s patent record in context - here's where to go next.

Inari Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #5,291 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inari Medical, Inc. against Hydac Technology GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.